Osteoporosis drug could half number of redo hip replacement operations

Osteoporosis drug could half number of redo hip replacement operations

Researchers have found the osteoporosis drug, denosumab, could protect patients from osteolysis, reduce the need for re-operations, and reduce the health burden of this disease.

Read more

Source: Science Daily